Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Tempus AI, Inc. - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
TEM
Nasdaq
8071
www.tempus.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Tempus AI, Inc.
Why Investors Are Questioning Tempus AI, Inc. (TEM)’s Premium Valuation
- Nov 21st, 2026 7:51 am
NGS Reference Materials Market Insights and Competitive Landscape - Forecast to 2036 | Total Revenue to Reach $904.1 Million as Liquid Biopsy and IVD-Grade Standards Drive 10.7% CAGR
- Nov 20th, 2026 8:24 am
Natera vs. Tempus AI: Which Blood Test Pioneer Has the Better Stock Buy for 2027?
- Nov 19th, 2026 12:40 pm
Grail vs. Tempus AI: Which Healthcare Stock Is a Better Buy for 2027?
- Nov 19th, 2026 10:33 am
Tempus to Present 16 Abstracts at the 2026 San Antonio Breast Cancer Symposium
- Nov 19th, 2026 5:30 am
What's Going To Happen With Tempus AI Stock Soon?
- Nov 19th, 2026 4:34 am
Tempus AI: 3 Key Takeaways for Long-Term Investors
- Nov 18th, 2026 11:55 pm
AI in Clinical Trials - Global Strategic Business Report 2026: Secure Share of a US$4.1 Billion Market by 2032 with IQVIA, Microsoft, Tempus AI, and Saama
- Nov 18th, 2026 8:37 am
Cathie Wood Adds Nvidia Stock Before Earnings While Selling Palantir
- Nov 16th, 2026 10:43 am
Tempus AI And 2 More AI Healthcare Stocks
- Nov 14th, 2026 11:08 pm
Cathie Wood Boosts Bets On 2 AI Firms Amid Nvidia’s Huang Upheaval — Here’s How Her Trading Week Unfolded
- Nov 12th, 2026 9:41 pm
IPO Edge NYSE Firesides Scheduled for Monday, December 7
- Nov 12th, 2026 3:00 pm
Could You Have Seen The Run In Guardant Health Stock Coming?
- Nov 11th, 2026 2:34 pm
Tempus to Present Six Abstracts Accepted at the 2026 Connective Tissue Oncology Society Annual Meeting
- Nov 11th, 2026 6:30 am
The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
- Nov 11th, 2026 6:10 am
Tempus AI (TEM) Surged on Data Business Momentum and MRD Testing Expansion
- Nov 10th, 2026 10:44 am
SOTERIA Collaborates with Tempus to Advance Precision Oncology for U.S. Military and Veterans Battling Cancer
- Nov 9th, 2026 2:39 pm
PSNL Deal Alert: Personalis $16.25 per Share Merger Under Investigation – Contact BFA Law about the Pending Merger Investigation
- Nov 9th, 2026 3:36 am
MarketBeat Week in Review – 11/2 - 11/6
- Nov 7th, 2026 5:00 am
TEM Q3 Earnings Call Highlights Growth and 2027 Pricing Upside
- Nov 3rd, 2026 7:00 am
Scroll